Aristotle Atlantic Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Sell |
|
|||||
|
2025
Q1 | $23.3M | Sell |
|
|||||
|
2024
Q4 | $20.6M | Sell |
|
|||||
|
2024
Q3 | $25.2M | Buy |
|
|||||
|
2024
Q2 | $24.6M | Sell |
|
|||||
|
2024
Q1 | $24.5M | Buy |
|
|||||
|
2023
Q4 | $11.2M | Buy |
|
|||||
|
2023
Q3 | $3.22M | Sell |
|
|||||
|
2023
Q2 | $3.39M | Buy |
|
|||||
|
2023
Q1 | $549K | Buy |
|
|||||
|
2022
Q4 | $499K | Sell |
|
|||||
|
2022
Q3 | $503K | Buy |
|
|||||
|
2022
Q2 | $417K | Buy |
|
|||||
|
2022
Q1 | $240K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $12.4M | Buy |
|